Drug intelligence / Profile preview

bupleurum xuanfuhua decoction

Development stage: Unknown
Lead developer: 中国中医科学院望京医院
Administration: Oral

Overview

Bupleurum Xuanfuhua Decoction is a Traditional Chinese Medicine (TCM) herbal formula primarily composed of *Bupleurum chinense* (Chai Hu) and *Inula britannica* or *Inula japonica* (Xuan Fu Hua). It is traditionally used to regulate Qi, resolve phlegm, and harmonize the liver and spleen. In clinical research, it is being investigated for its potential to treat autoimmune thyroid diseases, specifically Hashimoto's thyroiditis, by modulating the immune response and improving thyroid function. The formula is typically administered as an oral decoction and is studied for its ability to reduce thyroid autoantibodies and stabilize thyroid hormone levels.

Other names: Chaihu Xuanfuhua TangChai Hu Xuan Fu Hua Tang

Beyond the preview

Go deeper on bupleurum xuanfuhua decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on bupleurum xuanfuhua decoction.

Explore the full profile